| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | AbbVie Tracking for New Highs in 2024 | 13 | MarketBeat | ||
| Di | A surprise leader for April's largest TV drug ad spender as Otsuka, Lundbeck knock AbbVie from its perch | 5 | FiercePharma | ||
| Mo | AbbVie to Present at the Bank of America Securities Healthcare Conference | 9 | MarijuanaStocks.com | ||
| Fr | AbbVie Inc. - 10-Q, Quarterly Report | 18 | SEC Filings | ||
| 01.05. | BeiGene, AbbVie patent spat to get trial from USPTO appeals board | 14 | Seeking Alpha | ||
| 01.05. | Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors | 14 | CNBC | ||
| 30.04. | Ludwigshafen: Abbvie investiert | 16 | Deutsches Ärzteblatt | ||
| 30.04. | Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher | 12 | MarketBeat | ||
| 29.04. | Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition | 17 | Investing.com | ||
| 29.04. | AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales | 10 | Investor's Business Daily | ||
| 29.04. | Peeling Back The Layers: Exploring AbbVie Through Analyst Insights | 9 | Benzinga.com | ||
| 29.04. | AbbVie investiert rund 150 Millionen Euro in die Zukunft der Spitzenforschung am Standort Ludwigshafen | 380 | news aktuell | Ludwigshafen (ots) - - Modernste Rahmenbedingungen für Forscher*innen im Kampf gegen u.a. Alzheimer und Krebs - Investition unterstreicht Bedeutung des rheinland-pfälzischen Standorts für AbbVie im... ► Artikel lesen | |
| 29.04. | These Pharmaceutical Firms are on Sale: AbbVie, Pfizer, and Gilead | 49 | Baystreet.ca | ||
| 29.04. | AbbVie shares positive results for Rinvoq in head-to-head atopic dermatitis study | 9 | PMLiVE | ||
| 29.04. | Street View: AbbVie's Humira to be key debate through 2025 | 11 | Reuters | ||
| 26.04. | Why AbbVie Stock Stumbled Today Despite the Earnings Beat | 53 | The Motley Fool | ||
| 26.04. | AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump | 39 | Investopedia | ||
| 26.04. | AbbVie stock slides 6% amid concerns about falling Humira sales | 35 | Seeking Alpha | ||
| 26.04. | AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod | 17 | FiercePharma | ||
| 26.04. | AbbVie tries to reassure investors on Humira biosimilar threat | 17 | BioPharma Dive |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| PALANTIR TECHNOLOGIES | 2.483 |
| EVOTEC | 2.301 |
| NEL | 2.224 |
| INFINEON | 1.687 |
| TUI | 1.554 |
| BAYER | 1.355 |
| DEUTSCHE BANK | 1.236 |
| NVIDIA | 1.188 |
| DEUTSCHE LUFTHANSA | 1.125 |
| BYD | 1.034 |
| VARTA | 996 |
| RHEINMETALL | 934 |
| MERCEDES-BENZ | 889 |
| AIXTRON SE | 828 |
| SUPER MICRO COMPUTER | 827 |
| TESLA | 826 |
| RENK GROUP | 823 |
| PLUG POWER | 813 |
| TEAMVIEWER | 812 |
| COMMERZBANK | 768 |
| RWE | 767 |
| ALLIANZ | 743 |
| SIEMENS ENERGY | 731 |
| VOLKSWAGEN | 712 |
| WALT DISNEY | 697 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
